Biomarkers for glioma immunotherapy: the next generation

Journal of Neuro-oncology
Jennifer S SimsJeffrey N Bruce

Abstract

The term "biomarker" historically refers to a single parameter, such as the expression level of a gene or a radiographic pattern, used to indicate a broader biological state. Molecular indicators have been applied to several aspects of cancer therapy: to describe the genotypic and phenotypic state of neoplastic tissue for prognosis, to predict susceptibility to anti-proliferative agents, to validate the presence of specific drug targets, and to evaluate responsiveness to therapy. For glioblastoma (GBM), immunohistochemical and radiographic biomarkers accessible to the clinical lab have informed traditional regimens, but while immunotherapies have emerged as potentially disruptive weapons against this diffusely infiltrating, heterogeneous tumor, biomarkers with strong predictive power have not been fully established. The cancer immunotherapy field, through the recently accelerated expansion of trials, is currently leveraging this wealth of clinical and biological data to define and revise the use of biomarkers for improving prognostic accuracy, personalization of therapy, and evaluation of responses across the wide variety of tumors. Technological advancements in DNA sequencing, cytometry, and microscopy have facilitated the exp...Continue Reading

References

Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·A J WongB Vogelstein
Oct 11, 1991·Journal of Neurosurgery·B C LiangH S Greenberg
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P A HumphreyD D Bigner
May 1, 1985·Journal of Neuropathology and Experimental Neurology·C J WikstrandD D Bigner
Feb 1, 1989·Journal of Neurosurgery·D BarbaE H Oldfield
Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A J WongB Vogelstein
Nov 18, 1971·The New England Journal of Medicine·J Folkman
May 7, 1971·Brain Research·L F EngB Gerstl
Aug 12, 1971·The New England Journal of Medicine·J Folkman
Sep 1, 1980·Neurology·F H Hochberg, A Pruitt
Feb 1, 1994·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·C F HessM Bamberg
Jan 2, 1994·International Journal of Cancer. Journal International Du Cancer·J SchlegelM Kiessling
Apr 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G StragliottoJ Y Delattre
Dec 22, 1998·The Journal of Experimental Medicine·A J ZajacR Ahmed
Jul 3, 1999·Japanese Journal of Cancer Research : Gann·H TsurushimaT Ohno
Dec 22, 1999·British Journal of Cancer·S BalesariaR A Fisher
Feb 1, 2000·Laboratory Investigation; a Journal of Technical Methods and Pathology·H FujisawaH Ohgaki
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·C OhlénP D Greenberg
Apr 18, 2003·Oncogene·Paul S MischelStanley F Nelson
Jun 27, 2003·Cancer Immunology, Immunotherapy : CII·Tsutomu KobayashiRyuichi Tanaka
Aug 2, 2003·Journal of Neuro-oncology·Anuj K Mahindra, Stuart A Grossman
Mar 5, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Amy B HeimbergerKenneth Aldape
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Mar 11, 2005·The New England Journal of Medicine·Monika E HegiRoger Stupp
Apr 2, 2005·Journal of Neuro-oncology·Jing HanRaj K Puri
Aug 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Linda M LiauMichael D Roth
May 30, 2006·Advances in Immunology·Alan J KormanJames P Allison
Jul 22, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Peter E FecciJohn H Sampson
Mar 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sandeep KunwarUNKNOWN Cintredekin Besudotox Intraparenchymal Study Group

❮ Previous
Next ❯

Citations

Oct 12, 2015·Current Treatment Options in Oncology·Martha R Neagu, David A Reardon
Apr 2, 2016·Bulletin du cancer·Antoine SchernbergFrédéric Dhermain
Nov 26, 2015·Immunotherapy·Anda-Alexandra CalinescuMaria Graciela Castro
Sep 16, 2015·Nature Reviews. Neurology·Manfred Westphal, Katrin Lamszus
Aug 12, 2015·Nature Reviews. Neurology·Matthias PreusserJohn H Sampson
Jul 15, 2015·Cellular and Molecular Neurobiology·Jie SunYuchan Wang
Jun 5, 2016·Proceedings of the National Academy of Sciences of the United States of America·Jennifer S SimsJeffrey N Bruce
Mar 18, 2017·Current Oncology Reports·Aaron C TanMustafa Khasraw
Apr 19, 2018·Critical Reviews in Clinical Laboratory Sciences·Ivana Jovčevska
Apr 1, 2017·Human Vaccines & Immunotherapeutics·Giannis SokratousKeyoumars Ashkan
Jul 10, 2016·Journal of Neuro-oncology·Guido H JajamovichSangeetha Somayajula
Mar 17, 2017·Journal of Immunology Research·Boyuan HuangXiaoxing Xiong
May 1, 2021·Brain Sciences·Marika LanzaSalvatore Cuzzocrea
Sep 18, 2021·Neuropathology and Applied Neurobiology·Gayaththri Vimalathas, Bjarne Winther Kristensen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Related Papers

Expert Review of Proteomics
Sonal Gupta, Kanika Chawla
Critical Reviews in Oncology/hematology
Renaud SabatierFrançois Bertucci
Current Oncology Reports
Alexandra Drakaki, David F McDermott
© 2022 Meta ULC. All rights reserved